Neutral
Executive pay, ownership and governance detailed in Catalyst (NASDAQ: CPRX) 2025 10-K/A
Catalyst Pharmaceuticals Inc. (CPRX) filed an amended 2025 annual report (10-K/A) to provide detailed information on directors, executive officers, co...